Camber is made up of three groups  with one common goal: to be the best generics company in the industry. Camber Pharmaceuticals is rapidly growing and had an industry-leading 28 product approvals in 2022. With the support of our parent company, Hetero, we are poised to have a record number of product approvals and launches in 2023. Hetero, a world leader in API production and vertical manufacturing, is the foundation upon which Camber has maintained a 99% service level for our customers for the past two  years. Hetero is investing over $250 million in the next three years in Camber products. The research and development team consists of over 1,000 scientists working to expand the types of drugs Camber offers, including novel delivery systems and complex molecules.

Biotechnology

Health Care

Life Sciences

Medical Devices

Pharmaceutical

Camber Pharmaceuticals Inc

Camber Pharmaceuticals Inc's headquarters in Piscataway, NJ, United States

Kon Ostaficiuk

Dennis Herrera

Veera Kamjula

Shea Flood

Victor Mazzacone

Ron Cerminaro

Kirk Hessels

H. D. Smith

Tom Destefano

Stephen Rutledge

Surya Gandikota

Description

People (18)

Clay Smith

Kirk Hessels

Clayton Smith

Argenis Perez

Alix Jean-Louis

Ariel Strauss

Danny Lorenzo

Srikanth Namburi

Chris Trotta

Greg Boyer

Allison Prezioso

Aditya Reddy Mali

Victor Mazzacone

Mistry Jiten

Veera Kamjula

Jenna Maffucci

Shawn Terlaje

Shea Flood

Jobs